+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 145 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5397831
Description Jump to:
The global point-of-care glucose testing market size is expected to reach USD 4.51 billion by 2030, registering a CAGR of 4.1% over the forecast period. An increase in the demand for Point-of-Care Testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient’s bedside. The easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings. The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism have propelled the companies to launch innovative glucose meters in the market.

Various companies are investing in the development of needle-less devices to offer painless management of diabetes. For instance, GlucoTrack, a product manufactured by Integrity Applications (Israel), performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. Eversense, painless glucose monitoring subcutaneous implant by Senseonics, quantifies glucose levels in interstitial fluid when placed beneath the skin. This is followed by data transmission to show the results in real-time. The latest no-code monitoring systems help in minimizing the errors that occur due to incorrect entry of strip codes. Whereas, others are incorporating noble metals, such as silver, gold, and platinum, which effectively reduce the electrical noise further improving accuracy.

Point-of-Care Glucose Testing Market Report Highlights

  • Accu-Chek Inform II accounted for the second-largest share in 2022 and is anticipated to maintain this trend throughout the forecast period
  • Bayer Contour blood glucose monitoring system is set to grow at a CAGR of 6.1% from 2023 to 2030
  • North America is the leading regional market due to the higher penetration of novel diagnostic techniques
  • Asia Pacific is estimated to register the fastest CAGR owing to the ever-increasing prevalence of diabetes and numerous untapped growth opportunities in diagnostics
  • Moreover, a robust network of local manufacturers has significantly contributed to the revenue generated in this region


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Point-of-Care (POC) Glucose Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Introduction of CLIA waived tests
3.4.1.2. Growing prevalence of diabetes
3.4.1.3. Rising demand for short turnaround time glucose POC testing
3.4.2. Market restraint analysis
3.4.2.1. Potential interference and calibration issues in glucose meters
3.4.2.2. Presence of ambiguous regulatory as well as reimbursement framework
3.5. Point-of-Care(POC) Glucose Testing Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Point-of-Care (POC) Glucose Testing Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Accu-Check Aviva Meter
4.1.2. Onetouch Verio Flex
4.1.3. i-STAT
4.1.4. Freestyle Lite
4.1.5. Bayer CONTOUR Blood Glucose Monitoring System
4.1.6. True Metrix
4.1.7. Accu-Check Inform II
4.1.8. StatStrip
4.1.9. Others
4.2. Product Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Point-of-Care (POC) Glucose Testing Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2030 for the following
4.5.1. Accu-Check Aviva Meter
4.5.1.1. Accu-Check Aviva Meter market estimates and forecast, 2016 - 2030
4.5.2. Onetouch Verio Flex
4.5.2.1. Onetouch Verio Flex market estimates and forecast, 2016 - 2030
4.5.3. i-STAT
4.5.3.1. I-STAT market estimates and forecast, 2016 - 2030
4.5.4. Freestyle Lite
4.5.4.1. Freestyle Lite market estimates and forecast, 2016 - 2030
4.5.5. Bayer CONTOUR Blood Glucose Monitoring System
4.5.5.1. Bayer CONTOUR Blood Glucose Monitoring System market estimates and forecast, 2016 - 2030
4.5.6. True Metrix
4.5.6.1. True Metrix market estimates and forecast, 2016 - 2030
4.5.7. Accu-Check Inform II
4.5.7.1. Accu-Check Inform II market estimates and forecast, 2016 - 2030
4.5.8. StatStrip
4.5.8.1. StatStrip market estimates and forecast, 2016 - 2030
4.5.9. Others
4.5.9.1. Others market estimates and forecast, 2016 - 2030
Chapter 5. Point-of-Care (POC) Glucose Testing Market: Regional Estimates & Trend Analysis
5.1. Regional market share analysis, 2022 & 2030
5.2. Regional Marketplace: Key Takeaways
5.3. North America
5.3.1. SWOT Analysis
5.3.2. Market estimates and forecast, 2016-2030 (Revenue, USD Million)
5.3.3. U.S.
5.3.3.1. Country Dynamics
5.3.3.2. Country Variables
5.3.3.3. Competitive Landscape
5.3.3.4. Regulatory/Reimbursement Framework
5.3.3.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.3.4. Canada
5.3.4.1. Country Dynamics
5.3.4.2. Country Variables
5.3.4.3. Competitive Landscape
5.3.4.4. Regulatory/Reimbursement Framework
5.3.4.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. SWOT Analysis
5.4.2. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.4.3. UK
5.4.3.1. Country Dynamics
5.4.3.2. Country Variables
5.4.3.3. Competitive Landscape
5.4.3.4. Regulatory/Reimbursement Framework
5.4.3.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.4.4. Germany
5.4.4.1. Country Dynamics
5.4.4.2. Country Variables
5.4.4.3. Competitive Landscape
5.4.4.4. Regulatory/Reimbursement Framework
5.4.4.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.4.5. France
5.4.5.1. Country Dynamics
5.4.5.2. Country Variables
5.4.5.3. Competitive Landscape
5.4.5.4. Regulatory/Reimbursement Framework
5.4.5.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.4.6. Italy
5.4.6.1. Country Dynamics
5.4.6.2. Country Variables
5.4.6.3. Competitive Landscape
5.4.6.4. Regulatory/Reimbursement Framework
5.4.6.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.4.7. Spain
5.4.7.1. Country Dynamics
5.4.7.2. Country Variables
5.4.7.3. Competitive Landscape
5.4.7.4. Regulatory/Reimbursement Framework
5.4.7.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.4.8. Denmark
5.4.8.1. Country Dynamics
5.4.8.2. Country Variables
5.4.8.3. Competitive Landscape
5.4.8.4. Regulatory/Reimbursement Framework
5.4.8.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.4.9. Sweden
5.4.9.1. Country Dynamics
5.4.9.2. Country Variables
5.4.9.3. Competitive Landscape
5.4.9.4. Regulatory/Reimbursement Framework
5.4.9.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.4.10. Norway
5.4.10.1. Country Dynamics
5.4.10.2. Country Variables
5.4.10.3. Competitive Landscape
5.4.10.4. Regulatory/Reimbursement Framework
5.4.10.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. SWOT Analysis
5.5.2. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.5.3. Japan
5.5.3.1. Country Dynamics
5.5.3.2. Country Variables
5.5.3.3. Competitive Landscape
5.5.3.4. Regulatory/Reimbursement Framework
5.5.3.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.5.4. China
5.5.4.1. Country Dynamics
5.5.4.2. Country Variables
5.5.4.3. Competitive Landscape
5.5.4.4. Regulatory/Reimbursement Framework
5.5.4.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.5.5. India
5.5.5.1. Country Dynamics
5.5.5.2. Country Variables
5.5.5.3. Competitive Landscape
5.5.5.4. Regulatory/Reimbursement Framework
5.5.5.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.5.6. Australia
5.5.6.1. Country Dynamics
5.5.6.2. Country Variables
5.5.6.3. Competitive Landscape
5.5.6.4. Regulatory/Reimbursement Framework
5.5.6.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.5.7. Thailand
5.5.7.1. Country Dynamics
5.5.7.2. Country Variables
5.5.7.3. Competitive Landscape
5.5.7.4. Regulatory/Reimbursement Framework
5.5.7.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.5.8. South Korea
5.5.8.1. Country Dynamics
5.5.8.2. Country Variables
5.5.8.3. Competitive Landscape
5.5.8.4. Regulatory/Reimbursement Framework
5.5.8.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. SWOT Analysis
5.6.2. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.6.3. Brazil
5.6.3.1. Country Dynamics
5.6.3.2. Country Variables
5.6.3.3. Competitive Landscape
5.6.3.4. Regulatory/Reimbursement Framework
5.6.3.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.6.4. Mexico
5.6.4.1. Country Dynamics
5.6.4.2. Country Variables
5.6.4.3. Competitive Landscape
5.6.4.4. Regulatory/Reimbursement Framework
5.6.4.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.6.5. Argentina
5.6.5.1. Country Dynamics
5.6.5.2. Country Variables
5.6.5.3. Competitive Landscape
5.6.5.4. Regulatory/Reimbursement Framework
5.6.5.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. SWOT Analysis
5.7.2. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.7.3. South Africa
5.7.3.1. Country Dynamics
5.7.3.2. Country Variables
5.7.3.3. Competitive Landscape
5.7.3.4. Regulatory/Reimbursement Framework
5.7.3.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.7.4. Saudi Arabia
5.7.4.1. Country Dynamics
5.7.4.2. Country Variables
5.7.4.3. Competitive Landscape
5.7.4.4. Regulatory/Reimbursement Framework
5.7.4.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.7.5. UAE
5.7.5.1. Country Dynamics
5.7.5.2. Country Variables
5.7.5.3. Competitive Landscape
5.7.5.4. Regulatory/Reimbursement Framework
5.7.5.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
5.7.6. Kuwait
5.7.6.1. Country Dynamics
5.7.6.2. Country Variables
5.7.6.3. Competitive Landscape
5.7.6.4. Regulatory/Reimbursement Framework
5.7.6.5. Market estimates and forecast, 2016 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2022
6.3.4. F. Hoffmann-La Roche Ltd.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Abbott
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Nipro
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. PlatInium Equity Advisors, LLC (Lifescan, Inc.)
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Nova Biomedical
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. ACON Laboratories
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Trividia Health, Inc.
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Prodigy Diabetes Care, LLC
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Bayer AG/Ascensia Diabetes Care Holdings AG
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. EKF Diagnostics
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 3 North America Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 5 Canada Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 6 Canada Point-of-Care (POC) Glucose Testing market, by application, 2018 - 2030 (USD Million)
Table 7 Europe Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 8 Europe Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
Table 9 Germany Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 10 UK Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 11 France Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 12 Italy Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 13 Spain Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 14 Russia Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 15 APAC Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 16 APAC Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
Table 17 China Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 18 Japan Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 19 India Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 20 Thailand Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 21 South Korea Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 22 Australia Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 23 Latin America Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 24 Latin America Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
Table 25 Brazil Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 26 Mexico Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 27 Argentina Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 28 Colombia Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 29 Middle East and Africa Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 30 Middle East and Africa Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
Table 31 Saudi Arabia Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 32 South Africa Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
Table 33 UAE Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Point-of-Care (POC) Glucose Testing market:market outlook
Fig. 14 Point-of-Care (POC) Glucose Testing market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Point-of-Care (POC) Glucose Testing market driver impact
Fig. 20 Point-of-Care (POC) Glucose Testing market restraint impact
Fig. 21 Point-of-Care (POC) Glucose Testing market strategic initiatives analysis
Fig. 22 Point-of-Care (POC) Glucose Testing market: product movement analysis
Fig. 23 Point-of-Care (POC) Glucose Testing market: product outlook and key takeaways
Fig. 24 Accu Check Aviva Meter market estimates and forecast, 2018 - 2030
Fig. 25 Onetouch Verio Flex market estimates and forecast, 2018 - 2030
Fig. 26 i-STAT market estimates and forecast, 2018 - 2030
Fig. 27 Freestyle Lite market estimates and forecast, 2018 - 2030
Fig. 28 Bayer CONTOUR blood glucose monitoring system market estimates and forecast, 2018 - 2030
Fig. 29 True Metrix market estimates and forecast, 2018 - 2030
Fig. 30 Accu-Chek Inform II market estimates and forecast, 2018 - 2030
Fig. 31 StatStrip market estimates and forecast, 2018 - 2030
Fig. 32 Others market estimates and forecast, 2018 - 2030
Fig. 33 Global Point-of-Care (POC) Glucose Testing market: regional movement analysis
Fig. 34 Global Point-of-Care (POC) Glucose Testing market: regional outlook and key takeaways
Fig. 35 Global market share and leading players
Fig. 36 North America market share and leading players
Fig. 37 Europe market share and leading players
Fig. 38 Asia Pacific market share and leading players
Fig. 39 Latin America market share and leading players
Fig. 40 Middle East & Africa market share and leading players
Fig. 41 North America: SWOT
Fig. 42 Europe SWOT
Fig. 43 Asia Pacific SWOT
Fig. 44 Latin America SWOT
Fig. 45 MEA SWOT
Fig. 46 North America, by country
Fig. 47 North America
Fig. 48 North America market estimates and forecast, 2018 - 2030
Fig. 49 U.S.
Fig. 50 U.S. market estimates and forecast, 2018 - 2030
Fig. 51 Canada
Fig. 52 Canada market estimates and forecast, 2018 - 2030
Fig. 53 Europe
Fig. 54 Europe. market estimates and forecast, 2018 - 2030
Fig. 55 UK
Fig. 56 UK market estimates and forecast, 2018 - 2030
Fig. 57 Germany
Fig. 58 Germany market estimates and forecast, 2018 - 2030
Fig. 59 France
Fig. 60 France market estimates and forecast, 2018 - 2030
Fig. 61 Italy
Fig. 62 Italy market estimates and forecast, 2018 - 2030
Fig. 63 Spain
Fig. 64 Spain market estimates and forecast, 2018 - 2030
Fig. 65 Russia
Fig. 66 Russia market estimates and forecast, 2018 - 2030
Fig. 67 Asia Pacific
Fig. 68 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 69 China
Fig. 70 China market estimates and forecast, 2018 - 2030
Fig. 71 Japan
Fig. 72 Japan market estimates and forecast, 2018 - 2030
Fig. 73 India
Fig. 74 India market estimates and forecast, 2018 - 2030
Fig. 75 Thailand
Fig. 76 Thailand market estimates and forecast, 2018 - 2030
Fig. 77 South Korea
Fig. 78 South Korea market estimates and forecast, 2018 - 2030
Fig. 79 Australia
Fig. 80 Australia market estimates and forecast, 2018 - 2030
Fig. 81 Latin America
Fig. 82 Latin America market estimates and forecast, 2018 - 2030
Fig. 83 Brazil
Fig. 84 Brazil market estimates and forecast, 2018 - 2030
Fig. 85 Mexico
Fig. 86 Mexico market estimates and forecast, 2018 - 2030
Fig. 87 Argentina
Fig. 88 Argentina market estimates and forecast, 2018 - 2030
Fig. 89 Colombia
Fig. 90 Colombia market estimates and forecast, 2018 - 2030
Fig. 91 Middle East and Africa
Fig. 92 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 93 Saudi Arabia
Fig. 94 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 95 South Africa
Fig. 96 South Africa market estimates and forecast, 2018 - 2030
Fig. 97 UAE
Fig. 98 UAE market estimates and forecast, 2018 - 2030
Fig. 99 Participant categorization- Point-of-Care (POC) Glucose Testing market
Fig. 100 Market share of key market players- Point-of-Care (POC) Glucose Testing market

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Nipro
  • PlatInium Equity Advisors, LLC (Lifescan, Inc.)
  • Nova Biomedical
  • ACON Laboratories
  • Trividia Health, Inc.
  • Prodigy Diabetes Care, LLC
  • Bayer AG/Ascensia Diabetes Care Holdings AG
  • EKF Diagnostics

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages145
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 3.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.51 Billion
Compound Annual Growth Rate4.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Point-of-Care Glucose Testing Market by Product (Accu Check Aviva Meter, Accu-Chek Inform II, Bayer Contour Blood Glucose Monitoring System), Mode of Purchase (OTC Testing Product, Prescription-Based Testing Product), End-User - Forecast 2024-2030 - Product Image

Global Point-of-Care Glucose Testing Market by Product (Accu Check Aviva Meter, Accu-Chek Inform II, Bayer Contour Blood Glucose Monitoring System), Mode of Purchase (OTC Testing Product, Prescription-Based Testing Product), End-User - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Point-of-Care Glucose Testing Global Market Report 2024 - Product Image

Point-of-Care Glucose Testing Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Point-of-Care Glucose Testing Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Point-of-Care Glucose Testing Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 206 Pages
  • Global
From
Point-of-Care Glucose Testing Market By Product Type, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Image

Point-of-Care Glucose Testing Market By Product Type, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • 408 Pages
  • Global
From
2023 Global Forecast for Point-Of-Care Glucose Testing Market (2024-2029 Outlook) - High Tech & Emerging Markets Report - Product Image

2023 Global Forecast for Point-Of-Care Glucose Testing Market (2024-2029 Outlook) - High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.